天康生物(002100) - 2016 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2016 was ¥962,437,096.19, a decrease of 6.08% compared to the same period last year[8]. - Net profit attributable to shareholders increased by 97.16% to ¥96,557,711.33 from ¥53,739,664.88 in the previous year[8]. - Basic earnings per share doubled to ¥0.10, compared to ¥0.06 in the same period last year[8]. - Operating profit, total profit, and net profit attributable to the parent company were 104.07 million, 104.85 million, and 96.56 million respectively, representing increases of 120.66%, 88.82%, and 97.16% year-on-year, driven by rising pig prices[17]. - The company expects net profit attributable to shareholders for the first half of 2016 to be between 168.66 million and 210.82 million, representing a year-on-year increase of 20% to 50%[25]. Cash Flow and Assets - The net cash flow from operating activities improved significantly, reaching ¥183,192,982.36, a 617.85% increase from the previous year's negative cash flow[8]. - Net cash flow from operating activities increased by 618% year-on-year, mainly due to a decrease in cash paid for raw material purchases[21]. - The total assets at the end of the reporting period were ¥3,882,445,810.93, reflecting a 2.03% increase from the previous year[8]. - The net assets attributable to shareholders increased by 4.11% to ¥2,448,712,860.26 compared to the end of the previous year[8]. Shareholder Information - The total number of shareholders at the end of the reporting period was 67,639, with the top ten shareholders holding significant stakes[13]. - The company did not engage in any repurchase transactions during the reporting period[14]. Income and Expenses - The company reported non-operating income of ¥763,636.17, primarily from government subsidies and other income[11]. - Financial expenses decreased by 67.73% to 3.99 million, mainly due to a reduction in loans by 358 million compared to the previous year[17]. Receivables and Payables - Accounts receivable increased by 102% compared to the beginning of the year, mainly due to planned government procurement debts from the pharmaceutical business[18]. - Prepaid accounts decreased by 39% compared to the beginning of the year, as raw materials purchased in advance were completed and stored during the reporting period[18]. - Other receivables rose by 70% compared to the beginning of the year, primarily due to an increase in travel advances[19]. - Tax payable increased by 52% compared to the beginning of the year, attributed to a rise in taxable projects for monthly VAT[20]. Minority Interests - Minority interests increased by 114% compared to the beginning of the year, mainly due to the acquisition of 70% of Henan Tiankang Hongzhan Agricultural Technology Co., Ltd. and a 50% stake in Tiankang Ruifu Feed Co., Ltd.[20].